Experts share expertise to direct and guide organizations of
asset tracking technologies from cultivation to consumer
April 6, 2022 – Pittsburgh, PA – The Cannabis Work Group of AIM North America (AIM NA), the premier alliance for the automated data capture technologies industry, including barcode, RFID, IoT, NFC, and RTLS, released a whitepaper that provides an overview and general recommendations to help guide the effort toward cannabis traceability from cultivation to consumer.
The Track and Trace for the Cannabis Industry from Cultivation to Consumer Whitepaper, was written for all members of the cannabis supply chain — farmers and growers, processors, manufacturers, distributors, dispensaries, even consumers — who benefit from implementing AIDC solutions. This whitepaper will
“Growers, processers, and retailers are navigating significant challenges in a relatively new industry. The need to comply with traceability regulation adds a layer of complexity to what it is they do,” stated Elizabeth Sinclair, Cannabis Work Group Chair and Director of Marketing for BarTender® Software. “This whitepaper is a primer on the AIDC technologies that will enable regulatory compliance and process efficiencies at scale as the cannabis industry grows.”
The Cannabis Work Group Membership represent all industries and organizations that use, implement, resell, or develop automatic identification and data capture (AIDC) technologies. These technologies are essential to enabling adoption, growth, and interoperability to those who depend on accurate, available, and identifiable data.
For additional information and to inquire about membership, please click here.
UDI Work Group Submits Comments to the FDA's Draft Guidance for Transition Plan for Medical Devices Issued Emergency Use Authorization (EUAs) during COVID.
The AIM North America UDI Work Group submitted comments to the U.S. FDA request for comments related to the Draft Guidance for Transition Plan for Medical Devices Issued Emergency Use Authorization (EUAs) during COVID. In addition to supporting the comments submitting by AHRMM, the group also recommended that EUAs should be required to submit a minimal set of device identification data to the Global UDI database (GUDID) to provide a single repository of data for all medical device and requiring EUAs to meet the basic tenants of the UDI Rule for unique identification and submission to GUDID is less burdensome than the risk to patient safety. Read complete comments here.
AIM North America is taking the time to honor the winners of their highly recognized awards